- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ ↓ -0.37%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 400 SMA
Returns
CAGR returns till date
CAGR returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan and its peers as on 4 September, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan | 26.92% | -0.37% | -0.46% | 2.16% | 12% | 26.94% | - | - | - | - |
| SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH | -7.91% | -0.26% | -2.12% | -5.27% | 1.36% | -11.5% | 6.13% | 12.68% | 16.3% | 13.61% |
| SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth | -3.02% | -0.17% | -1.53% | -2.39% | 4.57% | 1.47% | 9.83% | 8.62% | 13.96% | 11.79% |
| SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH | 24.16% | -0.73% | -0.83% | 0.65% | 12.85% | 21.26% | 24.72% | 18.34% | 26.09% | 14.89% |
| SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH | 1.91% | 0.38% | -0.48% | -2.16% | 0.07% | 6.25% | 14.25% | 16.58% | 20.56% | 15.22% |
| SBI COMMA Fund - DIRECT PLAN - Growth | 8.9% | 0.51% | 1.08% | 2.28% | 2.79% | 15.59% | 16.87% | 11.85% | 21.16% | 15.89% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | - | - | - | - | - | - | - | - | 52.37% | 1.73% |
Discrete returns (monthly)
| Month | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | 1.22% | -1.38% | -4.65% | 6.99% | -4.36% | 7.84% | 5.11% | 6.59% | 3.59% | 3.8% |
Returns from spefic dates
| Description | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|---|
| Returns | 18.1% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 99.53% | 0.00% (Arbitrage: 0.00%) | 0.00% | 0.00% | 0.47% |
Equity
| Name | Symbol / ISIN | Sector | Weight % | Other links |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 9.66% | |
| Divis Laboratories Ltd. | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 9.14% | |
| Max Healthcare Institute Limited | MAXHEALTH (INE027H01010) | Healthcare Services | 4.82% | |
| Aster DM Quality Care Limited | ASTERDM (INE914M01019) | Healthcare Services | 4.70% | |
| Lupin Ltd. | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 4.67% | |
| Cipla Ltd. | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 4.64% | |
| Alkem Laboratories Ltd. | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 3.67% | |
| Acutaas Chemicals Limited | ACUTAAS (INE00FF01025) | Pharmaceuticals & Biotechnology | 3.58% | |
| Anthem Biosciences Limited | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 3.56% | |
| Neuland Laboratories Limited | NEULANDLAB (INE794A01010) | Pharmaceuticals & Biotechnology | 3.40% | |
| Ipca Laboratories Ltd. | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 3.22% | |
| Global Health Limited | MEDANTA (INE474Q01031) | Healthcare Services | 3.05% | |
| Fortis Healthcare Limited | FORTIS (INE061F01013) | Healthcare Services | 2.79% | |
| Krishna Institute Of Medical Sciences Limited | KIMS (INE967H01025) | Healthcare Services | 2.70% | |
| Glenmark Pharmaceuticals Ltd. | GLENMARK (INE935A01035) | Pharmaceuticals & Biotechnology | 2.59% | |
| Jupiter Life Line Hospitals Limited | (INE682M01020) | Healthcare Services | 2.45% | |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 2.28% | |
| Shilpa Medicare Ltd | SHILPAMED (INE790G01031) | Pharmaceuticals & Biotechnology | 2.25% | |
| Vijaya Diagnostic Centre Limited | VIJAYA (INE043W01024) | Healthcare Services | 2.23% | |
| Metropolis Healthcare Ltd. | METROPOLIS (INE112L01020) | Healthcare Services | 2.14% | |
| Zydus Lifesciences Limited | ZYDUSLIFE (INE010B01027) | Pharmaceuticals & Biotechnology | 2.10% | |
| Biocon Ltd. | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 2.01% | |
| Dr Reddys Laboratories Ltd. | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 1.92% | |
| Wockhardt Ltd. | WOCKPHARMA (INE049B01025) | Pharmaceuticals & Biotechnology | 1.89% | |
| Sai Life Sciences Limited | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 1.62% | |
| Rubicon Research Limited | RUBICON (INE506V01022) | Pharmaceuticals & Biotechnology | 1.61% | |
| Apollo Hospitals Enterprise Ltd. | APOLLOHOSP (INE437A01024) | Healthcare Services | 1.58% | |
| Thyrocare Technologies Ltd. | THYROCARE (INE594H01019) | Healthcare Services | 1.42% | |
| Ajanta Pharma Limited | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 1.28% | |
| Eris Lifesciences Ltd | ERIS (INE406M01024) | Pharmaceuticals & Biotechnology | 1.25% | |
| CORONA REMEDIES LIMITED | CORONA (INE02ZQ01018) | Pharmaceuticals & Biotechnology | 1.24% | |
| Gland Pharma Ltd. | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 1.07% | |
| Jubilant Pharmova Limited | JUBLPHARMA (INE700A01033) | Pharmaceuticals & Biotechnology | 1.01% | |
| BAJAJ HEALTHCARE LIMITED | BAJAJHCARE (INE411U01027) | Pharmaceuticals & Biotechnology | 0.65% | |
| Novartis India Ltd. | NOVARTIND (INE234A01025) | Pharmaceuticals & Biotechnology | 0.51% | |
| Laxmi Dental Limited | LAXMIDENTL (INE0WO601020) | Healthcare Equipment & Supplies | 0.47% | |
| Cohance Lifesciences Limited | COHANCE (INE03QK01018) | Pharmaceuticals & Biotechnology | 0.36% |
Portfolio data is as on date 31 July, 2026
NAV history
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 4 September, 2026 | 22.406 | -0.37% |
| 3 September, 2026 | 22.49 | 0.24% |
| 2 September, 2026 | 22.436 | 0.08% |
| 1 September, 2026 | 22.418 | -0.88% |
| 31 August, 2026 | 22.618 | 0.48% |
| 28 August, 2026 | 22.51 | -0.04% |
| 27 August, 2026 | 22.52 | 0.58% |
| 26 August, 2026 | 22.391 | 0.64% |
| 25 August, 2026 | 22.248 | 0.69% |
| 24 August, 2026 | 22.096 | 0.17% |
| 21 August, 2026 | 22.058 | -0.19% |
| 20 August, 2026 | 22.099 | -0.05% |
| 19 August, 2026 | 22.111 | -0.85% |
| 18 August, 2026 | 22.3 | 0.43% |
| 17 August, 2026 | 22.204 | 0.2% |
| 14 August, 2026 | 22.159 | -0.03% |
| 13 August, 2026 | 22.166 | -0.06% |
| 12 August, 2026 | 22.179 | -0.87% |
| 11 August, 2026 | 22.373 | 0.69% |
| 10 August, 2026 | 22.22 | 0.14% |
| 7 August, 2026 | 22.19 | 0.48% |
| 6 August, 2026 | 22.085 | 0.18% |
| 5 August, 2026 | 22.046 | 0.52% |
| 4 August, 2026 | 21.933 | -0.27% |
| 3 August, 2026 | 21.992 | 0.93% |
| 31 July, 2026 | 21.79 | 0.08% |
| 30 July, 2026 | 21.772 | -0.3% |
| 29 July, 2026 | 21.838 | 1.37% |
| 28 July, 2026 | 21.543 | -0.11% |
| 27 July, 2026 | 21.566 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
The latest NAV of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan is 22.406 as on 4 September, 2026.What are YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
The YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are 26.92% as on 4 September, 2026.What are 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
The 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are 26.94% as on 4 September, 2026.What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)Holding period Tax rate Less than 1 year (STCG) 20% More than 1 year (LTCG) Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.